Indian-made pneumonia vaccine is set to break Big Pharma’s hold on Gavi funds

By the end of the year, a new pneumonia vaccine produced by Serum Institute of India is set to enter the market at a much lower price than Gavi currently pays. Key vaccine actors call this a “game changer” that could reduce prices and save children’s lives.

Development Today is a subscription-based online journal. To subscribe click here.

If you are already a subscriber to Development Today please log in.

Would you like to know more about Development Today? Click here.